NEUROGENIC TUMOUR

This adverse event was reported 13 times

NEUROGENIC TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SELUMETINIB 1 0.0006
1 CRIZOTINIB 1 0.0001
2 ROMOSOZUMAB-AQQG 1 0.0001
3 BICALUTAMIDE 1 0.0001
4 BUSULFAN 1 0.0001
5 LURASIDONE HYDROCHLORIDE 1 0.0000
6 DABRAFENIB 1 0.0000
7 NIRAPARIB 1 0.0000
8 TRAMETINIB 1 0.0000
9 PROCHLORPERAZINE 1 0.0000
See all drugs enriched for association with NEUROGENIC TUMOUR

NEUROGENIC TUMOUR is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Phenothiazine [EPC] 1 0.0000
1 Folate Analog [EPC] 1 0.0000
2 Vitamin A [EPC] 1 0.0000
3 Nicotinic Acid [EPC] 1 0.0000
4 Antidote [EPC] 1 0.0000
5 Androgen Receptor Inhibitor [EPC] 1 0.0000
6 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
7 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
8 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
9 Alkylating Drug [EPC] 1 0.0000
See all drug classes enriched for association with NEUROGENIC TUMOUR